Windtree Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Windtree Therapeutics
WINT Stock  USD 0.08  0.01  14.29%   
Analyzing historical trends in various income statement and balance sheet accounts from Windtree Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Windtree Therapeutics' valuation are summarized below:
Gross Profit
-17.8 M
Market Capitalization
2.3 M
Enterprise Value Revenue
706.0804
Earnings Share
62.6
Quarterly Revenue Growth
(1.00)
There are currently one hundred twenty fundamental gauges for Windtree Therapeutics that can be evaluated and compared over time across peers. All traders should confirm Windtree Therapeutics' prevalent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 1 M in 2025. Enterprise Value is likely to drop to about 1.1 M in 2025

Windtree Therapeutics Total Revenue

0.0

Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.8 K, Interest Expense of 223.2 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 665, Dividend Yield of 0.58 or PTB Ratio of 0.0873. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Windtree Stock
Check out the analysis of Windtree Therapeutics Correlation against competitors.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Windtree Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets41.9 M27.9 M50.5 M
Pretty Stable
Short and Long Term Debt Total1.7 M1.8 M13 M
Very volatile
Other Current Liabilities2.9 M2.7 M6 M
Slightly volatile
Total Current Liabilities8.3 M5.7 M8.7 M
Pretty Stable
Accounts Payable1.6 M1.9 M1.5 M
Very volatile
Liabilities And Stockholders Equity41.9 M27.9 M50.5 M
Pretty Stable
Non Current Liabilities Total14.1 M12.2 M19.7 M
Slightly volatile
Other Current Assets1 M795 K1.4 M
Slightly volatile
Other Stockholder Equity436.3 M856.6 M614 M
Slightly volatile
Total Liabilities21.5 M17.9 M28.4 M
Slightly volatile
Total Current Assets2.4 M2.6 M20.9 M
Slightly volatile
Short Term Debt799 K841 K3.4 M
Very volatile
Property Plant And Equipment Net1.1 M1.2 M1.5 M
Pretty Stable
Cash1.7 M1.8 M18.8 M
Slightly volatile
Non Current Assets Total18.3 M25.3 M28.3 M
Slightly volatile
Cash And Short Term Investments1.7 M1.8 M19.7 M
Slightly volatile
Common Stock Total Equity14.5 K15.3 K709.1 K
Slightly volatile
Property Plant And Equipment Gross2.7 M5 M2.1 M
Slightly volatile
Common Stock294.6 K305 K743.1 K
Slightly volatile
Non Currrent Assets Other8.6 K9 K425 K
Slightly volatile
Inventory23.1 K24.3 K87.1 K
Slightly volatile
Other Liabilities13.2 M12.6 M7.1 M
Slightly volatile
Long Term Debt2.6 M2.8 M8.7 M
Pretty Stable
Property Plant Equipment2.1 M3.1 M1.9 M
Slightly volatile
Long Term Debt Total2.6 M2.8 M9.6 M
Pretty Stable
Capital Surpluse662.9 M908.8 M648.2 M
Slightly volatile
Short and Long Term Debt628 K661 K9.4 M
Slightly volatile
Non Current Liabilities Other3.6 M3.8 M8 M
Slightly volatile
Deferred Long Term Liabilities12.1 M19.3 M8.3 M
Slightly volatile
Intangible Assets38.6 M24.1 M62.1 M
Slightly volatile
Capital Lease Obligations1.3 M1.2 M1.6 M
Very volatile

Windtree Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization79.8 K84 K597 K
Slightly volatile
Interest Expense223.2 K235 K1.1 M
Slightly volatile
Other Operating Expenses28.9 M25 M28.8 M
Pretty Stable
Total Operating Expenses28.7 M24.9 M28.4 M
Pretty Stable
Selling General Administrative10.7 M8.7 M10.3 M
Very volatile
Research Development18.7 M16.3 M17.7 M
Pretty Stable
Interest Income66.5 K70 K1.5 M
Slightly volatile
Selling And Marketing Expenses5.7 M10.6 M5.6 M
Slightly volatile
Preferred Stock And Other Adjustments5.1 M5.7 M6.3 M
Slightly volatile
Reconciled Depreciation160.2 K84 K194.1 K
Very volatile

Windtree Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow4.2 M4.5 M19.6 M
Pretty Stable
Depreciation79.8 K84 K434.9 K
Slightly volatile
Total Cash From Financing Activities12.1 M12.7 M23.4 M
Slightly volatile
End Period Cash Flow1.7 M1.8 M18.9 M
Slightly volatile
Stock Based Compensation432.2 K455 K81.7 M
Slightly volatile
Exchange Rate Changes308 K542.8 K250.2 K
Slightly volatile
Issuance Of Capital Stock5.2 M5.5 M24.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio665633357
Slightly volatile
Dividend Yield0.580.640.702
Slightly volatile
Stock Based Compensation To Revenue37.0839.0482.8068
Slightly volatile
Capex To Depreciation0.140.14290.7062
Pretty Stable
EV To Sales587559301
Slightly volatile
Sales General And Administrative To Revenue75.6572.0431.3532
Slightly volatile
Research And Ddevelopement To Revenue60.5557.6745.8437
Slightly volatile
Capex To Revenue0.90.870.8726
Very volatile
Cash Per Share32.1433.832250.4 M
Slightly volatile
Income Quality9.058.61891.8066
Slightly volatile
Intangibles To Total Assets0.620.86570.7652
Pretty Stable
Current Ratio0.430.45023.2192
Slightly volatile
Capex Per Share0.220.22822.2 M
Slightly volatile
Revenue Per Share8919381.3 M
Slightly volatile
Interest Debt Per Share37.1639.11913.2 M
Slightly volatile
Debt To Assets0.06210.06540.5965
Very volatile
Ebt Per Ebit0.06810.07170.9253
Slightly volatile
Quick Ratio0.430.45023.2173
Slightly volatile
Net Income Per E B T2.892.751.3158
Slightly volatile
Cash Ratio0.30.31122.2421
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.131.00081.0188
Pretty Stable
Fixed Asset Turnover0.09890.10.8299
Slightly volatile
Debt Ratio0.06210.06540.5965
Very volatile
Price Sales Ratio665633357
Slightly volatile
Asset Turnover0.00140.00150.0526
Pretty Stable

Windtree Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1 M1.1 M48.9 M
Pretty Stable
Enterprise Value1.1 M1.1 M39.9 M
Pretty Stable

Windtree Fundamental Market Drivers

Forward Price Earnings0.3652
Cash And Short Term Investments1.8 M

Windtree Upcoming Events

1st of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Windtree Therapeutics Financial Statements

Windtree Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue178.2 K169.3 K
Cost Of Revenue84 K79.8 K
Stock Based Compensation To Revenue 39.04  37.08 
Sales General And Administrative To Revenue 72.04  75.65 
Research And Ddevelopement To Revenue 57.67  60.55 
Capex To Revenue 0.87  0.90 
Revenue Per Share 937.64  890.76 
Ebit Per Revenue(144.58)(137.35)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY